Unlocking the power of RWE and structured data to transform clinical trial outcomes
The clinical trial ecosystem faces mounting challenges, including fragmented data sources, escalating costs, and increasingly intricate trial designs,...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s global experts in life sciences support clinical development and medical affairs teams to optimize their role as the key interface between health technology manufacturers and the scientific and medical community. Our focus is helping our medical affairs clients unlock the clinical potential of new technologies for the benefit of patients, providers, payers, and the broader healthcare system. Our projects encompass vision and strategy setting, medical and clinical planning, customer insights, evidence generation, publication and communications, launch readiness, and field excellence.
Contact CRA’s medical affairs experts to explore what CRA can tailor to your needs.
The clinical trial ecosystem faces mounting challenges, including fragmented data sources, escalating costs, and increasingly intricate trial designs,...
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success,...
CRA is a proud sponsor of the MAPS organization. Ayushman Ghosh to co-host the roundtable discussion titled “Strategic applications of Machine...
CRA is a proud sponsor of this event, the largest global gathering of Medical Affairs Professionals. Ayushman Ghosh to co-host the roundtable discussion titled...